Coronavirus Disease 2019
📧 Sign up to get email alerts when something new happens for Coronavirus Disease 2019.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University-sponsored trial evaluating pharmacokinetics, pharmacodynamics, and safety of understudied drugs given to children as part of…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: COVID-19 Associated Lymphopenia Pathogenesis Study in Blood
This completed clinical trial investigated the pathogenesis of COVID-19-associated lymphopenia in blood. It was sponsored by the National In…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia
A completed clinical trial evaluating Paxlovid (nirmatrelvir/ritonavir) for COVID-19 in Saudi Arabia has posted results.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Early Diagnosis of Clinical Evolution From SARS-CoV-2
This is a completed clinical trial update on early diagnosis of clinical evolution in COVID-19 infection.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects [Phase 1]
Phase 1 study of AK119, an anti-CD73 antibody, evaluating safety in healthy subjects for COVID-19 has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults [Phase 2]
A Phase 2 study evaluating the safety and tolerability of AZD7442 in Chinese adults has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
A terminated clinical trial evaluating a predictive model for severity and disease progression in influenza-like illness, including COVID-19…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura
A completed clinical trial update on the evolution of COVID-19 patients in Extremadura.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia [NA]
Clinical trial registry entry for evaluating the LIAISON NES diagnostic assay for Influenza A/B, RSV, and COVID-19 in symptomatic patients i…
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19 [Phase 2]
Phase 2 double-blind, placebo-controlled trial evaluating safety and efficacy of leronlimab in patients with long COVID-19 has completed wit…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19
Observational study of convalescent plasma for treatment of veterans with COVID-19; study completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 [Phase 1]
A Phase 1 placebo-controlled trial evaluating Bempegaldesleukin (BEMPEG; NKTR-214) plus standard of care in patients with mild COVID-19 has …
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial [Phase 3]
Phase 3 trial evaluating anti-coronavirus therapies to prevent progression of COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Immunogenicity After COVID-19 Vaccines in Adapted Schedules [Phase 4]
Phase 4 trial update examining immunogenicity of COVID-19 vaccines with adapted schedules; completed study.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization [Phase 4]
Phase 4 trial investigating urine alkalinization to prevent coronavirus-induced acute kidney injury; the study was terminated with results p…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: COVID-19: Human Epidemiology and Response to SARS-CoV-2
A completed clinical trial update from NIAID examining COVID-19 epidemiology and the immune response to SARS-CoV-2, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 [Phase 2]
Phase 2 dose-confirmation study assessing safety, reactogenicity, and immunogenicity of the CVnCoV vaccine in healthy adults for COVID-19; s…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) [Phase 2]
Phase 2 clinical trial of silmitasertib (CX-4945) in patients with severe COVID-19 was terminated.
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection [Phase 3]
Phase 3 trial evaluating rivaroxaban to reduce major thrombotic events, hospitalization, and death in medically ill outpatients with acute C…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: COVID-19 and Anti-CD14 Treatment Trial [Phase 2]
Phase 2 trial of anti-CD14 treatment for COVID-19/SARS-CoV-2 has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine [Phase 3]
Phase 3 clinical trial of a recombinant COVID-19 vaccine (CHO cell) combined with influenza vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) [Phase 2, Phase 3]
Phase 2/3 trial of TJ003234 (anti-GM-CSF monoclonal antibody) in severe COVID-19 completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients [Phase 3]
A Phase 3 clinical trial evaluating carrimycin for safety and efficacy in hospitalized patients with COVID-19 has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 [Phase 2]
Phase 2 clinical trial evaluating masitinib with isoquercetin and best supportive care in hospitalized patients with moderate to severe COVI…
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of leronlimab for mild to moderate COVID-19 has completed with posted results.